Developer of engineered cell therapies designed to enhance research and development processes. The company's platform utilizes patented, non-viral technology for the rapid delivery of small molecules, nucleic acids, proteins, and gene-editing complexes to immune cells, enabling biopharmaceutical companies to accelerate their research and manufacturing efforts while maintaining high cell viability and function.